Mostrar el registro sencillo del ítem
Effects of curcumin on neurological diseases: focus on astrocytes
dc.contributor.author | Eghbaliferiz S. | |
dc.contributor.author | Farhadi F. | |
dc.contributor.author | Barreto G.E. | |
dc.contributor.author | Majeed M. | |
dc.contributor.author | Sahebkar A. | |
dc.date.accessioned | 2020-09-02T22:17:16Z | |
dc.date.available | 2020-09-02T22:17:16Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1007/s43440-020-00112-3 | |
dc.identifier.citation | 72, 4, 769-782 | |
dc.identifier.issn | 17341140 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4375 | |
dc.description | Astrocytes are the most abundant glial cells in the central nervous system, and are important players in both brain injury and neurodegenerative disease. Curcumin (1,7-bis[4-hydroxy-3-methoxyphenyl]-1,6-heptadiene-3,5-dione), the major active component of turmeric, belongs to the curcuminoid family that was originally isolated from the plant Curcuma longa. Several studies suggest that curcumin may have a beneficial impact on the brain pathology and aging. These effects are due to curcumin’s antioxidant, free-radical scavenging, and anti-inflammatory activity. In light of this, our current review aims to discuss the role of astrocytes as essential players in neurodegenerative diseases and suggest that curcumin is capable of direct inhibition of astrocyte activity with a particular focus on its effects in Alexander disease, Alzheimer's disease, ischemia stroke, spinal cord injury, Multiple sclerosis, and Parkinson’s disease. © 2020, Maj Institute of Pharmacology Polish Academy of Sciences. | |
dc.language.iso | en | |
dc.publisher | Springer | |
dc.subject | Brain | |
dc.subject | Curcuminoids | |
dc.subject | Neurodegenerative disease | |
dc.subject | curcumin | |
dc.subject | Alzheimer disease | |
dc.subject | antiinflammatory activity | |
dc.subject | antioxidant activity | |
dc.subject | astrocyte | |
dc.subject | brain edema | |
dc.subject | brain ischemia | |
dc.subject | cell activation | |
dc.subject | degenerative disease | |
dc.subject | depression | |
dc.subject | drug bioavailability | |
dc.subject | drug mechanism | |
dc.subject | epilepsy | |
dc.subject | glioma | |
dc.subject | human | |
dc.subject | microglia | |
dc.subject | multiple sclerosis | |
dc.subject | nervous system inflammation | |
dc.subject | neurologic disease | |
dc.subject | neuropathic pain | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | Parkinson disease | |
dc.subject | Persian Gulf syndrome | |
dc.subject | Review | |
dc.subject | spinal cord injury | |
dc.title | Effects of curcumin on neurological diseases: focus on astrocytes | |
dc.type | Review |